The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000132.4(F8):c.5303G>A (p.Arg1768His)

CA10568007

627328 (ClinVar)

Gene: F8
Condition: hemophilia A
Inheritance Mode: X-linked inheritance
UUID: 4f3c8b67-eb47-4289-b4da-2951df274143
Approved on: 2024-02-09
Published on: 2024-07-11

HGVS expressions

NM_000132.4:c.5303G>A
NM_000132.4(F8):c.5303G>A (p.Arg1768His)
NC_000023.11:g.154906490C>T
CM000685.2:g.154906490C>T
NC_000023.10:g.154134765C>T
CM000685.1:g.154134765C>T
NC_000023.9:g.153787959C>T
NG_011403.1:g.121234G>A
NG_011403.2:g.121234G>A
ENST00000360256.9:c.5303G>A
ENST00000360256.8:c.5303G>A
NM_000132.3:c.5303G>A
More

Pathogenic

Met criteria codes 5
PS3 PS4 PP3 PP4_Moderate PM2_Supporting
Not Met criteria codes 1
PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F8 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Coagulation Factor Deficiency VCEP
The c.5303G>A (p.Arg1768His) variant is completely absent from gnomAD v2.1.1 and v3.1.1, which meets PM2_Supporting. This missense variant has a REVEL score of 0.819 and meets PP3 criteria (threshold >0.6). At least 7 patients are reported in the literature with mild hemophilia A, meeting F8 phenotype criteria for PP4_Moderate and PS4 (PMID: 29296726, 17222201, 12871415, 21166991, 16972227, 24452774). This variant is known to have discrepant factor VIII levels, with chromogenic (two-stage) being 2-fold lower than one-stage assay levels (EAHAD database, PMID: 32232366). Finally, a COS-1 cell line was used to demonstrate decreased factor VIII activity and antigen levels (PMID: 30997536). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS3, PS4, PM2_Supporting, PP3, PP4_Moderate.
Met criteria codes
PS3
Evidence of decreased F8 antigen and activity in a COS-1 cell line.
PS4
Variant report in at least 6 published probands with mild hemophilia A. MLOF case counted towards for PP4.
PP3
REVEL score is 0.819, which is above the cutoff of 0.6.
PP4_Moderate
Male with mild hemophilia A with 47% one-stage factor VIII activity level. Chromogenic factor VIII level not provided. Variant is known to be discrepant.
PM2_Supporting
Variant only seen in 1 female in gnomAD v2.1.1 and v3.1.
Not Met criteria codes
PM5
Arg1768Cys has also been reported in at least two individuals with mild hemophilia A; however, there is not enough evidence to reach a likely pathogenic classification at this time.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.